AstraZeneca confirms constipation drug deal with ProStrakan

09-03-2016

AstraZeneca confirms constipation drug deal with ProStrakan

vitma / Shutterstock.com

Pharmaceutical company AstraZeneca agreed a deal with ProStrakan Group centring on the rights to the Moventig (naloxegol) drug in Europe.


AstraZeneca, ProStrakan, Moventig, naloxegol, Kyowa Hakko Kirin Co, constipation, Luke Miels,

LSIPR